Fezolinetant for hot flashes in men on prostate cancer treatment
Treatments studied
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a new medication called fezolinetant to reduce hot flashes (sudden feelings of intense heat) in men receiving hormone therapy for prostate cancer. Hot flashes are a common side effect of this treatment, and this study aims to see if fezolinetant can help relieve them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with prostate cancer (adenocarcinoma) that is either localized or has spread
- You have been on androgen deprivation therapy (hormone-blocking treatment) for at least 3 months
- You experience at least 4 hot flashes per day on average
- You are in generally good health with a Karnofsky score of 70% or higher (able to care for yourself and do light activities)
- Your liver and kidneys are functioning well (no cirrhosis, liver disease, or severe kidney problems)
- You are not currently taking medications for hot flashes, depression, or certain other conditions that could interfere with the study drug
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication called fezolinetant to see if it reduces hot flashes in men undergoing hormone therapy for prostate cancer. If you experience frequent hot flashes, this treatment might help alleviate them.
This study is testing how a new drug (fezolinetant) is processed in the body when given to men with prostate cancer and healthy men. It helps see if other prostate cancer drugs interfere with fezolinetant, which might be used for other conditions in the future.
This trial tests if acupuncture can reduce the daily discomfort from hot flashes caused by hormone therapy (androgen deprivation therapy) for prostate cancer. It may help men who are bothered by frequent or intense hot flashes find better relief.
This study tests whether a wearable cooling or heating device can help reduce hot flashes caused by hormone therapy for prostate cancer. You will use the device for 12 weeks and report how often and how much your hot flashes bother you.
This study tests whether real acupuncture works better than fake acupuncture for reducing hot flashes (sudden episodes of intense heat and sweating) in men with prostate cancer who are on hormone therapy. If acupuncture helps, it could offer relief without more medications.
This trial tests a combination of fasudil hydrochloride and immunotherapy for men with metastatic castration-resistant prostate cancer that has stopped responding to chemotherapy and hormone therapy. The goal is to see if this new approach can help control the cancer.
Hear when a new Vasomotor Symptoms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.